Early-Life RSV Infection and Childhood Asthma
In the INSPIRE trial, avoidance of severe respiratory syncytial virus (RSV) infection in the first year of life of healthy, full-term infants was associated with
Michael Posey
May 22, 2023
In the INSPIRE trial, avoidance of severe respiratory syncytial virus (RSV) infection in the first year of life of healthy, full-term infants was associated with
The extended half-life monoclonal antibody nirsevimab protected term and late-preterm infants against hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection and very severe
Three review articles examine the possible uses of biologic agents in treating pediatric asthma, controlling the atopic march, and treating monogenic systemic autoinflammatory diseases in
“As we increase our understanding of the immunologic continuum from a healthy immune system to preclinical rheumatoid arthritis to early and chronic disease, new opportunities
Artemis-deficient severe combined immunodeficiency (ART-SCID) in newly diagnosed infants responded to an infusion of lentiviral gene-corrected autologous CD34+ cells, a study shows. Artemis, a DNA-repair
Lancet: Challenges and Opportunities for Educating Health Professionals After the COVID-19 pandemic Diabetes Care: Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of
Clinical Infectious Diseases: Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review Vaccine: Towards